International Clinical Trial: to add an oral drug Imeglimin which is established for diabetes mellitus in uncontrolled diabetes

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117220) titled 'to add an oral drug Imeglimin which is established for diabetes mellitus in uncontrolled diabetes' on Sept. 8.

Study Type: Interventional

Study Design: Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Participant and Outcome Assessor Blinded

Primary Sponsor: ST Hospitals Private Limited

Condition: Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Intervention: Intervention1: interventio...